Double-blind controlled trial of the new preparation FZ. 560 in the symptomatic treatment of digestive disorders.
Porsio A, Borgia M·International journal of clinical pharmacology and biopharmacy
A controlled double-blind clinical trial was carried out to compare the effects of a new combination FZ. 560 in the symptomatic treatment of digestive disorders including a wide variety of symptoms. The combination contained fentonium bromide, 10 mg, dehydrocholic acid, 25 mg, pancreatin 3FU, 50 mg, and lactulose, 200…